The table as follows lists adverse reactions collected from clinical trial data, and adverse events reported from post-marketing sources. The frequencies are defined according to the following convention: Very common (>1/10), Common (>1/100 to <1/10), Uncommon (>1/1,000 to <1/100), Rare (>1/10,000 to <1/1,000), Very rare (<1/10,000), Unknown (cannot be estimated from the available data). (See table.)

View ADR Reporting Link